Physician profile
Kyle King
NPI 1609408442
$1,748.38
in general payments reported to CMS, 2019-2025
17 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $624 · 2023: $214 · 2024: $225 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.35 | 2021-2023 | |
| Amgen INC. | $411.68 | 2021-2025 | Krystexxa, Repatha, Otezla |
| Novo Nordisk INC | $157.47 | 2022-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $154.75 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.98 | 2021-2024 | Jardiance |
| Horizon Therapeutics Plc | $72.54 | 2022-2023 | Krystexxa |
| Lilly USA, LLC | $61.62 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $60.18 | 2022-2023 | Evusheld |
| Biohaven Pharmaceuticals, INC. | $42.87 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.33 | 2023 | |
| Philips North America LLC | $19.25 | 2024 | (5044) Mcot |
| Biohaven Pharmaceutical Holding Company LTD. | $18.27 | 2022 | |
| Glaxosmithkline, LLC. | $17.22 | 2025 | Shingrix |
| Dexcom, INC. | $15.27 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.22 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.